|
1
|
Liu CY, Hung MH, Wang DS, Chu PY, Su JC,
Teng TH, Huang CT, Chao TT, Wang CY, Shiau CW, et al: Tamoxifen
induces apoptosis through cancerous inhibitor of protein
phosphatase 2A-dependent phospho-Akt inactivation in estrogen
receptor-negative human breast cancer cells. Breast Cancer Res.
16:4312014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miano V, Ferrero G, Reineri S, Caizzi L,
Annaratone L, Ricci L, Cutrupi S, Castellano I, Cordero F and De
Bortoli M: Luminal long non-coding RNAs regulated by estrogen
receptor alpha in a ligand-independent manner show functional roles
in breast cancer. Oncotarget. 7:3201–3216. 2016.
|
|
3
|
Goldhirsch A, Gelber RD and Coates AS:
What are the long-term effects of chemotherapy and hormonal therapy
for early breast cancer? Nat Clin Pract Oncol. 2:440–441. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen JQ and Russo J: ERalpha-negative and
triple negative breast cancer: Molecular features and potential
therapeutic approaches. Biochim Biophys Acta. 1796:162–175.
2009.PubMed/NCBI
|
|
5
|
Kennecke H, Yerushalmi R, Woods R, Cheang
MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic
behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giacinti L, Claudio PP, Lopez M and
Giordano A: Epigenetic information and estrogen receptor alpha
expression in breast cancer. Oncologist. 11:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ottaviano YL, Issa JP, Parl FF, Smith HS,
Baylin SB and Davidson NE: Methylation of the estrogen receptor
gene CpG island marks loss of estrogen receptor expression in human
breast cancer cells. Cancer Res. 54:2552–2555. 1994.PubMed/NCBI
|
|
8
|
Wei J, Han B, Mao XY, Wei MJ, Yao F and
Jin F: Promoter methylation status and expression of estrogen
receptor alpha in familial breast cancer patients. Tumour Biol.
33:413–420. 2012. View Article : Google Scholar
|
|
9
|
Jing MX, Mao XY, Li C, Wei J, Liu C and
Jin F: Estrogen receptor-alpha promoter methylation in sporadic
basal-like breast cancer of Chinese women. Tumour Biol. 32:713–719.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao L, Wang L, Jin F, Ma W, Ren J, Wen X,
He M, Sun M, Tang H and Wei M: Silencing of estrogen receptor alpha
(ERalpha) gene by promoter hypermethylation is a frequent event in
Chinese women with sporadic breast cancer. Breast Cancer Res Treat.
117:253–259. 2009. View Article : Google Scholar
|
|
11
|
Ellis IO: Intraductal proliferative
lesions of the breast: Morphology, associated risk and molecular
biology. Mod Pathol. 23(Suppl 2): S1–S7. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hilton HN, Kantimm S, Graham JD and Clarke
CL: Changed lineage composition is an early event in breast
carcinogenesis. Histol Histopathol. 28:1197–1204. 2013.PubMed/NCBI
|
|
13
|
Beer N, Ali AS, de Savigny D, Al-Mafazy
AW, Ramsan M, Abass AK, Omari RS, Björkman A and Källander K:
System effectiveness of a targeted free mass distribution of long
lasting insecticidal nets in Zanzibar, Tanzania. Malar J.
9:1732010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bane A: Ductal carcinoma in situ: What the
pathologist needs to know and why. Int J Breast Cancer.
2013:9140532013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goodwin A, Parker S, Ghersi D and Wilcken
N: Post-operative radiotherapy for ductal carcinoma in situ of the
breast. Cochrane Database Syst Rev. 11:CD0005632013.PubMed/NCBI
|
|
16
|
Costarelli L, Campagna D, Mauri M and
Fortunato L: Intraductal proliferative lesions of the
breast-terminology and biology matter: Premalignant lesions or
preinvasive cancer. Int J Surg Oncol. 2012:5019042012.
|
|
17
|
Tavassoli FA: Correlation between gene
expression profiling-based molecular and morphologic classification
of breast cancer. Int J Surg Pathol. 18(Suppl): 167S–169S. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tavassoli FA: Lobular and ductal
intraepithelial neoplasia. Pathologe. 29(Suppl 2): 107–111. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tavassoli FA: Breast pathology: Rationale
for adopting the ductal intraepithelial neoplasia (DIN)
classification. Nat Clin Pract Oncol. 2:116–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kok LF, Lee MY, Tyan YS, Wu TS, Cheng YW,
Kung MF, Wang PH and Han CP: Comparing the scoring mechanisms of
p16INK4a immunohistochemistry based on independent nucleic stains
and independent cytoplasmic stains in distinguishing between
endocervical and endometrial adenocarcinomas in a tissue microarray
study. Arch Gynecol Obstet. 281:293–300. 2010. View Article : Google Scholar
|
|
21
|
Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW,
Hsu JD, Ruan A, Chao KC and Han CP: Scoring mechanisms of p16INK4a
immunohistochemistry based on either independent nucleic stain or
mixed cytoplasmic with nucleic expression can significantly signal
to distinguish between endocervical and endometrial adenocarcinomas
in a tissue microarray study. J Transl Med. 7:252009. View Article : Google Scholar
|
|
22
|
Manne U, Myers RB, Moron C, Poczatek RB,
Dillard S, Weiss H, Brown D, Srivastava S and Grizzle WE:
Prognostic significance of Bcl-2 expression and p53 nuclear
accumulation in colorectal adenocarcinoma. Int J Cancer.
74:346–358. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong G, DeVries S, Chew KL, Cha I, Ljung
BM and Waldman FM: Genetic changes in paired atypical and usual
ductal hyperplasia of the breast by comparative genomic
hybridization. Clin Cancer Res. 7:2410–2414. 2001.PubMed/NCBI
|
|
24
|
Di Bonito M, Cantile M, De Cecio R,
Liguori G and Botti G: Prognostic value of molecular markers and
cytogenetic alterations that characterize breast cancer precursor
lesions (Review). Oncol Lett. 6:1181–1183. 2013.PubMed/NCBI
|
|
25
|
Barr FE, Degnim AC, Hartmann LC, Radisky
DC, Boughey JC, Anderson SS, Vierkant RA, Frost MH, Visscher DW and
Reynolds C: Estrogen receptor expression in atypical hyperplasia:
Lack of association with breast cancer. Cancer Prev Res (Phila).
4:435–444. 2011. View Article : Google Scholar
|
|
26
|
Tan H, Zhong Y and Pan Z: Autocrine
regulation of cell proliferation by estrogen receptor-alpha in
estrogen receptor- alpha-positive breast cancer cell lines. BMC
Cancer. 9:312009. View Article : Google Scholar
|
|
27
|
Okolowsky N, Furth PA and Hamel PA:
Oestrogen receptor-alpha regulates non-canonical
Hedgehog-signalling in the mammary gland. Dev Biol. 391:219–229.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sprague BL, Trentham-Dietz A and Burnside
ES: Socioeconomic disparities in the decline in invasive breast
cancer incidence. Breast Cancer Res Treat. 122:873–878. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee
S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A and Medina D:
Ductal carcinoma in situ and the emergence of diversity during
breast cancer evolution. Clin Cancer Res. 14:370–378. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leonard GD and Swain SM: Ductal carcinoma
in situ, complexities and challenges. J Natl Cancer Inst.
96:906–920. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Allred DC, Brown P and Medina D: The
origins of estrogen receptor alpha-positive and estrogen receptor
alpha-negative human breast cancer. Breast Cancer Res. 6:240–245.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hovestadt V, Jones DT, Picelli S, Wang W,
Kool M, PA, Sultan M, Stachurski K, Ryzhova M, Warnatz HJ, et al:
Decoding the regulatory landscape of medulloblastoma using DNA
methylation sequencing. Nature. 510:537–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ballestar E and Esteller M: Epigenetic
gene regulation in cancer. Adv Genet. 61:247–267. 2008.PubMed/NCBI
|
|
34
|
Ramchandani S, Bhattacharya SK, Cervoni N
and Szyf M: DNA methylation is a reversible biological signal. Proc
Natl Acad Sci USA. 96:6107–6112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Timp W, Bravo HC, McDonald OG, Goggins M,
Umbricht C, Zeiger M, Feinberg AP and Irizarry RA: Large
hypomethylated blocks as a universal defining epigenetic alteration
in human solid tumors. Genome Med. 6:612014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hansen KD, Timp W, Bravo HC, Sabunciyan S,
Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al:
Increased methylation variation in epigenetic domains across cancer
types. Nat Genet. 43:768–775. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Reik W, Dean W and Walter J: Epigenetic
reprogramming in mammalian development. Science. 293:1089–1093.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lv M, Li B, Li Y, Mao X, Yao F and Jin F:
Predictive role of molecular subtypes in response to neoadjuvant
chemotherapy in breast cancer patients in Northeast China. Asian
Pac J Cancer Prev. 12:2411–2417. 2011.
|
